Page last updated: 2024-11-02

4-phenylbutyric acid and Carcinoma, Ehrlich Tumor

4-phenylbutyric acid has been researched along with Carcinoma, Ehrlich Tumor in 1 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fadeev, NP1
Kharisov, RI1
Kovan'ko, EG1
Pustovalov, YI1

Other Studies

1 other study available for 4-phenylbutyric acid and Carcinoma, Ehrlich Tumor

ArticleYear
Study of Antitumor Activity of Sodium Phenylbutyrate, Histon Deacetylase Inhibitor, on Ehrlich Carcinoma Model.
    Bulletin of experimental biology and medicine, 2015, Volume: 159, Issue:5

    Topics: Administration, Oral; Animals; Animals, Outbred Strains; Antineoplastic Agents; Carcinoma, Ehrlich T

2015